Nanjing Pharmaceutical Group Company Limited (SHA:600713)
China flag China · Delayed Price · Currency is CNY
5.12
-0.07 (-1.35%)
Nov 18, 2026, 3:00 PM CST

SHA:600713 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
638.08624.83570.63577.83595.67505.18
Depreciation & Amortization
255.47255.47268.92270.4260.47241.48
Other Amortization
47.4247.4216.5518.3416.117.44
Loss (Gain) From Sale of Assets
-293.31-293.31-3.85-1.75-23.79-60.54
Asset Writedown & Restructuring Costs
8.928.92----
Loss (Gain) From Sale of Investments
-5.08-5.08-4.02-8.58-2.88-7.57
Stock-Based Compensation
15.115.17.9317.5916.56-
Provision & Write-off of Bad Debts
141.24141.2426.84-16.0675.0911.48
Other Operating Activities
-1,022577.18532.13518.03485.02490.68
Change in Accounts Receivable
-1,584-1,584454.053,807-4,990-1,360
Change in Inventory
-617.7-617.7-502.37-13.45-1,271-460.58
Change in Accounts Payable
947.27947.27790.19-3,2554,1861,321
Change in Other Net Operating Assets
----0.98-
Operating Cash Flow
-1,49491.812,1361,906-682.31695.33
Operating Cash Flow Growth
--95.70%12.03%---

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-215.08-251.37-544.76-158.22-155.28-306.54
Sale of Property, Plant & Equipment
301.11269.17.096.693.3137.89
Cash Acquisitions
-201.97---0--2
Divestitures
-----0.2
Investment in Securities
134.3-219.9-27.6-23.950.1742.73
Other Investing Activities
-240.596.463.342.42.533.2
Investing Cash Flow
-222.23-195.7-561.93-173.18-59.26-224.52

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-22,03621,10227,95722,83329,058
Total Debt Issued
26,18022,03621,10227,95722,83329,058
Long-Term Debt Repaid
--21,875-21,396-28,535-22,757-28,065
Lease Payments
-95.68-95.68-113.22-117.46--110.57
Total Debt Repaid
-23,844-21,875-21,396-28,535-22,757-28,065
Net Debt Issued (Repaid)
2,336160.51-293.92-578.5375.14992.89
Issuance of Common Stock
----1,030-
Repurchase of Common Stock
-89.76-89.76-2.12-0.17--
Common Dividends Paid
-588.66-492.63-504.83-587.94-482.89-934.87
Other Financing Activities
229.45-9.05-38.919.87-155.37-27.17
Financing Cash Flow
1,887-430.93-839.77-1,157466.6230.85

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
170.8-534.83734.07576.46-274.95501.66

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-1,709-159.571,5911,748-837.59388.79
Free Cash Flow Growth
---8.99%---
Free Cash Flow Margin
-3.08%-0.29%2.96%3.26%-1.67%0.86%
Free Cash Flow Per Share
-1.16-0.111.221.35-0.670.37
Levered Free Cash Flow
-2,006-54.881,5613,356-2,793-338.73
Unlevered Free Cash Flow
-1,815138.251,7643,683-2,585-64.35
Free Cash Flow After Leases
-1,805-255.241,4781,631-837.59278.22

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
923.11905.691,007961.271,031742.15
Change in Working Capital
-1,280-1,280720.64530.61-2,105-502.81